Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 5/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.39 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | XBP1 | P17861 | 1/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 5/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5384226 | 0.91 | CA2 (0.54) | CA2TP53CES1FAAHCES2 | |
| SCHEMBL1704351 | 0.84 | GCLC (0.31) | CA2 | |
| SCHEMBL14814608 | 0.80 | GRIA1 (0.30) | — | |
| SCHEMBL9193536 | 0.78 | CA2 (0.41) | CA2TP53NPC1S1PR2S1PR4 | |
| SCHEMBL21075897 | 0.78 | CA2 (0.40) | CA2TP53NPC1S1PR2S1PR4 | |
| SCHEMBL6890549 | 0.78 | CA2 (0.40) | CA2TP53NPC1S1PR2S1PR4 | |
| SCHEMBL6589878 | 0.78 | — | — | |
| SCHEMBL14814609 | 0.78 | ATR (0.37) | CA2 | |
| SCHEMBL52570 | 0.78 | CA2 (0.52) | CA2TP53NPC1S1PR2S1PR4 | |
| SCHEMBL8976731 | 0.76 | CA2 (0.54) | CA2TP53CES1FAAHCES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250357553-A1 | LITHIUM ION SECONDARY BATTERY AND MANUFACTURING METHOD THEREOF | LG ENERGY SOLUTION LTD (KR) | 2025-11-20 | — | — | US | claimed |
| US-20250259802-A1 | HALOGENATED COMPOUNDS FOR ENERGY STORAGE DEVICE FORMULATIONS | MAXWELL TECH KOREA CO LTD (KR) | 2025-08-14 | — | — | US | claimed |
| EP-4511855-A1 | HALOGENATED COMPOUNDS FOR ENERGY STORAGE DEVICE FORMULATIONS | Maxwell Technologies Korea Co., Ltd. (KR) | 2025-02-26 | — | — | EP | claimed |
| EP-4510291-A1 | LITHIUM SECONDARY BATTERY AND MANUFACTURING METHOD THEREFOR | LG Energy Solution, Ltd. (KR) | 2025-02-19 | — | — | EP | claimed |
| CN-119317988-A | Halogenated compounds for energy storage device formulations | 麦克斯韦科技韩国有限公司 | 2025-01-14 | — | — | CN | claimed |
| WO-2023239074-A1 | LITHIUM SECONDARY BATTERY AND MANUFACTURING METHOD THEREFOR | 주식회사 엘지에너지솔루션 | 2023-12-14 | — | — | WO | claimed |
| WO-2023205034-A1 | HALOGENATED COMPOUNDS FOR ENERGY STORAGE DEVICE FORMULATIONS | MAXWELL TECHNOLOGIES KOREA CO., LTD. (KR) | 2023-10-26 | — | — | WO | claimed |
| CN-111261426-B | Super capacitor electrolyte and super capacitor | 深圳新宙邦科技股份有限公司 | 2022-08-09 | — | — | CN | claimed |
| CN-114121500-A | Electrolyte for super capacitor and super capacitor | 诺莱特电池材料(苏州)有限公司 | 2022-03-01 | — | — | CN | claimed |
| US-11250995-B2 | Advanced electrolyte systems and their use in energy storage devices | FASTCAP SYSTEMS CORPORATION (US) | 2022-02-15 | — | — | US | claimed |
| CN-110349759-B | Super capacitor electrolyte and super capacitor | 深圳新宙邦科技股份有限公司 | 2021-11-09 | — | — | CN | claimed |
| CN-113429259-A | Fluorine-containing compound and application thereof | 中国科学院上海有机化学研究所 | 2021-09-24 | — | — | CN | claimed |
| CN-111261426-A | Super capacitor electrolyte and super capacitor | 深圳新宙邦科技股份有限公司 | 2020-06-09 | — | — | CN | claimed |
| US-20170133716-A1 | BATTERY CELL AND BATTERY | Lithium Energy and Power GmbH & Co. KG (DE) | 2017-05-11 | — | — | US | claimed |
| EP-3166169-A1 | BATTERY CELL AND BATTERY | Lithium Energy and Power GmbH & Co. KG (DE) | 2017-05-10 | — | — | EP | claimed |
| US-9558894-B2 | Advanced electrolyte systems and their use in energy storage devices | FASTCAP SYSTEMS CORPORATION (US) | 2017-01-31 | — | — | US | claimed |
| US-9190216-B2 | Non-aqueous electrolyte solution for electric double-layer capacitor | TAIYO YUDEN CO., LTD. (JP) | 2015-11-17 | — | — | US | claimed |
| US-20140291568-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION FOR ELECTRIC DOUBLE-LAYER CAPACITOR | TAIYO YUDEN CO., LTD. (JP) | 2014-10-02 | — | — | US | claimed |
| CN-115775889-B | Fluorine-containing piperidine nitroxide free radical derivative, positive electrode electrolyte containing fluorine-containing piperidine nitroxide free radical derivative and application of fluorine-containing piperidine nitroxide free radical derivative | SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) | 2026-05-26 | — | — | CN | disclosed |
| US-4508660-A | Carbonylation of olefinically unsaturated nitriles and acids using a sulfone solvent | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250259802-A1 | HALOGENATED COMPOUNDS FOR ENERGY STORAGE DEVICE FORMULATIONS | VDAC2, VDAC3, PPARG | CA2 3666/4885TP53 3227/4885NPC1 2397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.